School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Jean Koff MD, MSc

  • Department of Hematology and Medical Oncology
    Associate Professor
  • (404) 778-3942
  • jkoff@emory.edu
Head shot of Jean Koff

Overview

Dr. Koff is a clinical investigator in the Bone Marrow and Stem Cell Transplant Center with a disease focus in lymphoma.

Dr. Koff received her MD and graduated magna cum laude from Emory University School of Medicine in Atlanta, Georgia. Her postgraduate medical education included a J. Willis Hurst Residency in Internal Medicine at Emory University and a Fellowship in Hematology and Medical Oncology at Winship Cancer Institute, where she was Chief Fellow in her final year.

She holds memberships with American Medical Association, American Society of Clinical Oncology and American Society of Hematology.

Academic Appointment

  • Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine

Education

Degrees

  • MD from Emory University School of Medicine

Research

Publications

  • Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma.
    Clin Lymphoma Myeloma Leuk Volume: 25 Page(s): e183 - e199.e8
    04/01/2025 Authors: Nastoupil LJ; Andersen CR; Ayers A; Wang Y; Habermann TM; Chihara D; Kahl BS; Link BK; Koff JL; Cohen JB
  • Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.
    Am J Hematol Volume: 100 Page(s): 606 - 615
    04/01/2025 Authors: Yamshon S; Koff JL; Larson MC; Kahl BS; Casulo C; Lossos IS; Haddadi S; Stanchina M; Chihara D; Ayers A
  • Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium.
    Blood Adv Volume: 9 Page(s): 1013 - 1023
    03/11/2025 Authors: Day JR; Larson MC; Durani U; Koff JL; Wang Y; Habermann TM; Lossos IS; Nastoupil LJ; Strouse C; Chihara D
  • Addressing Health Disparities in Hematologic Malignancies: from Genes to Outreach.
    Blood Cancer Discov Volume: 6 Page(s): 79 - 93
    03/04/2025 Authors: Flowers CR; Anantha RW; Leautaud V; Desai P; Donald CE; Hildebrandt MAT; Koff JL; Tamimi RM; Cozen W; Nze C
  • Plasma Cytokine and Chemokine Profiles Predict Efficacy and Toxicity of Anti-CD19 CAR-T Cell Therapy in Large B-Cell Lymphoma.
    Clin Lymphoma Myeloma Leuk
    02/20/2025 Authors: Zeng F; Zhang H; Wang S; Passang T; Li Y; Funk CR; Wyman S; O'Leary CB; Abousaud AI; Liu Y
  • Human immune organoids to decode B cell response in healthy donors and patients with lymphoma.
    Nat Mater Volume: 24 Page(s): 297 - 311
    02/01/2025 Authors: Zhong Z; Quiones-Prez M; Dai Z; Juarez VM; Bhatia E; Carlson CR; Shah SB; Patel A; Fang Z; Hu T
  • T Cells Spatially Regulate B Cell Receptor Signaling in Lymphomas through H3K9me3 Modifications.
    Adv Healthc Mater Volume: 14 Page(s): e2401192
    02/01/2025 Authors: Britto LS; Balasubramani D; Desai S; Phillips P; Trehan N; Cesarman E; Koff JL; Singh A
  • Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature.
    Blood Adv Volume: 8 Page(s): 5939 - 5948
    12/10/2024 Authors: Bommier C; Link BK; Gysbers BJ; Maurer MJ; Larson MC; Khurana A; Wang Y; Thompson CA; Chihara D; Alderuccio JP
  • Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.
    Haematologica Volume: 109 Page(s): 2177 - 2185
    07/01/2024 Authors: Maurer MJ; Casulo C; Larson MC; Habermann TM; Lossos IS; Wang Y; Nastoupil LJ; Strouse C; Chihara D; Martin P
  • Engineering Improved CAR T Cell Products with A Multi-Cytokine Particle Platform for Hematologic and Solid Tumors.
    Adv Healthc Mater Volume: 13 Page(s): e2302425
    06/01/2024 Authors: Lin HK; Uricoli B; Freeman R; Hossian AN; He Z; Anderson JYL; Neffling M; Legier JM; Blake DA; Doxie DB
  • The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
    Am J Hematol Volume: 99 Page(s): 408 - 421
    03/01/2024 Authors: Cerhan JR; Maurer MJ; Link BK; Feldman AL; Habermann TM; Jaye DL; Burack WR; McDonnell TJ; Vega F; Chapman JR
  • Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder.
    Curr Oncol Rep Volume: 25 Page(s): 883 - 895
    08/01/2023 Authors: Lee M; Abousaud A; Harkins RA; Marin E; Balasubramani D; Churnetski MC; Peker D; Singh A; Koff JL
  • Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.
    Blood Adv Volume: 7 Page(s): 2459 - 2462
    06/13/2023 Authors: Chang A; Koff JL; Lai L; Orellana-Noia VM; Surati M; Leal AMK; Ellis ML; Wali B; Moreno A; Linderman SL
  • 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
    Hematol Oncol Volume: 41 Suppl 2 Page(s): 597 - 598
    06/01/2023 Authors: Bond DA; Wei L; Yildiz V; Reneau J; Sawalha Y; Christian B; Brammer J; Epperla N; Koff J; Dendorfer A
  • Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma.
    Blood Volume: 141 Page(s): 1888 - 1893
    04/13/2023 Authors: Alderuccio JP; Reis IM; Koff JL; Larson MC; Chihara D; Zhao W; Haddadi S; Habermann TM; Martin P; Chapman JR
  • Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas.
    Nat Mater Volume: 22 Page(s): 511 - 523
    04/01/2023 Authors: Shah SB; Carlson CR; Lai K; Zhong Z; Marsico G; Lee KM; Flix Vlez NE; Abeles EB; Allam M; Hu T
  • Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms.
    Commun Biol Volume: 6 Page(s): 295
    03/20/2023 Authors: Taghi Khani A; Kumar A; Sanchez Ortiz A; Radecki KC; Aramburo S; Lee SJ; Hu Z; Damirchi B; Lorenson MY; Wu X
  • Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression.
    Front Transplant Volume: 2 Page(s): 1280993
    01/01/2023 Authors: Koff JL; Karadkhele GM; Switchenko JM; Rupji M; Little K; Larsen CP
  • Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.
    Cancer Res Commun Volume: 2 Page(s): 1684 - 1692
    12/01/2022 Authors: Chang A; Akhtar A; Lai L; Orellana-Noia VM; Linderman SL; McCook-Veal AA; Switchenko JM; Saini M; Valanparambil RM; Blum KA
  • CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.
    Clin Lymphoma Myeloma Leuk Volume: 22 Suppl 2 Page(s): S281 - S282
    10/01/2022 Authors: Chang A; Lai L; Akhtar A; Linderman S; Orellana-Noia V; Saini M; Valanparambil R; Blum K; Allen P; Lechowicz M
  • Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia.
    J Clin Invest Volume: 132
    09/15/2022 Authors: Chang A; Sholukh AM; Wieland A; Jaye DL; Carrington M; Huang M-L; Xie H; Jerome KR; Roychoudhury P; Greninger AL
  • Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.
    J Clin Oncol Volume: 40 Page(s): 3020 - 3031
    09/10/2022 Authors: Chang A; Akhtar A; Linderman SL; Lai L; Orellana-Noia VM; Valanparambil R; Ahmed H; Zarnitsyna VI; McCook-Veal AA; Switchenko JM
  • Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey.
    Blood Adv Volume: 6 Page(s): 2745 - 2756
    05/10/2022 Authors: Harkins RA; Patel SP; Lee MJ; Switchenko JM; Ansell SM; Bartlett NL; Blum KA; Cashen AF; Casulo C; Friedberg JW
  • Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.
    Lancet Haematol Volume: 9 Page(s): e289 - e300
    04/01/2022 Authors: Casulo C; Larson MC; Lunde JJ; Habermann TM; Lossos IS; Wang Y; Nastoupil LJ; Strouse C; Chihara D; Martin P
  • PI3K/ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.
    Blood Volume: 139 Page(s): 523 - 537
    01/27/2022 Authors: Funk CR; Wang S; Chen KZ; Waller A; Sharma A; Edgar CL; Gupta VA; Chandrakasan S; Zoine JT; Fedanov A
  • Gene expression profiling-based risk prediction and profiles of immune infiltration in diffuse large B-cell lymphoma.
    Blood Cancer J Volume: 11 Page(s): 2
    01/07/2021 Authors: Merdan S; Subramanian K; Ayer T; Van Weyenbergh J; Chang A; Koff JL; Flowers C
  • Cirmtuzumab, an Anti-ROR1 Antibody, in Combination with Ibrutinib: Clinical Activity in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL) from a Phase 1/2 Study
    Volume: 136
    11/05/2020 Authors: Lee HJ; Choi MY; Siddiqi T; Wierda WG; Barrientos JC; Lamanna N; Goldenberg A; Isufi I; Tuscano J; Subbiah S
  • Evaluating Outcomes for Autologous Hematopoietic Cell Transplantation for Diffuse Large B-Cell Lymphoma in the CAR-T Era
    Volume: 136
    11/05/2020 Authors: Santapuram PR; Rupji M; Graiser M; Waller EK; Blum KA; Allen PB; Koff JL; Heffner L; Lechowicz MJ; Lonial S
  • Linking Environmental Exposures to Molecular Pathogenesis in Non-Hodgkin Lymphoma Subtypes.
    Cancer Epidemiol Biomarkers Prev Volume: 29 Page(s): 1844 - 1855
    10/01/2020 Authors: Moubadder L; McCullough LE; Flowers CR; Koff JL
  • Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma.
    Cancer Volume: 126 Page(s): 3493 - 3503
    08/01/2020 Authors: Lee MJ; Koff JL; Switchenko JM; Jhaney CI; Harkins RA; Patel SP; Dave SS; Flowers CR
  • Machine learning prediction of survival in diffuse large B-cell lymphoma based on gene-expression profiling.
    Volume: 38
    05/20/2020 Authors: Merdan S; Subramanian K; Ayer T; Koff JL; Chang A; Van Weyenbergh J; Flowers C
  • Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell Lymphoma.
    Clin Lymphoma Myeloma Leuk Volume: 20 Page(s): 234 - 243.e10
    04/01/2020 Authors: Patel SP; Harkins RA; Lee MJ; Flowers CR; Koff JL
  • Insurance status impacts overall survival in Burkitt lymphoma.
    Volume: 60 Page(s): 3225 - 3234
    12/01/2019 Authors: Goldstein JS; Switchenko JM; Behera M; Flowers CR; Koff JL
  • Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma.
    Blood Volume: 134 Page(s): 19
    11/13/2019 Authors: Li X; Kositsky R; Reddy A; Love C; Naresh K; Koff JL; Nystrand I; Lepp S; Pasanen A; Karjalainen-Lindsberg M-L
  • Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma.
    Expert Rev Hematol Volume: 12 Page(s): 959 - 973
    11/01/2019 Authors: Harkins RA; Chang A; Patel SP; Lee MJ; Goldstein JS; Merdan S; Flowers CR; Koff JL
  • Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
    Clin Lymphoma Myeloma Leuk Volume: 19 Page(s): 699 - 708.e5
    11/01/2019 Authors: Ayers AA; Lyu L; Dance K; Ward KC; Flowers CR; Koff JL; McCullough LE
  • Examining genetic ancestry in diffuse large B-cell lymphoma (DLBCL)
    Volume: 79
    07/01/2019 Authors: Lee MJ; Jhaney CI; Flowers CR; Koff JL
  • Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.
    Clin Lymphoma Myeloma Leuk Volume: 19 Page(s): e312 - e320
    06/01/2019 Authors: Shah NN; Xi Y; Liu Y; Koff JL; Flowers CR; Behera M; Cohen JB
  • Influenza Vaccination Documentation Rates During the First Year After Diagnosis of Diffuse Large B Cell Lymphoma.
    Clin Lymphoma Myeloma Leuk Volume: 19 Page(s): 239 - 243
    04/01/2019 Authors: Chang A; Payne JB; Allen PB; Koff JL; Ahmed R; Flowers CR; Bednarczyk RA
  • Improving cancer-specific outcomes in solid organ transplant recipients: Where to begin?
    Cancer Volume: 125 Page(s): 838 - 842
    03/15/2019 Authors: Koff JL; Waller EK
  • History of autoimmune conditions and lymphoma prognosis.
    Blood Cancer J Volume: 8 Page(s): 73
    08/01/2018 Authors: Kleinstern G; Maurer MJ; Liebow M; Habermann TM; Koff JL; Allmer C; Witzig TE; Nowakowski GS; Micallef IN; Johnston PB
  • Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma.
    Leuk Lymphoma Volume: 59 Page(s): 1700 - 1709
    07/01/2018 Authors: Chen Q; Staton AD; Ayer T; Goldstein DA; Koff JL; Flowers CR
  • Impact of the posttransplant lymphoproliferative disorder subtype on survival.
    Cancer Volume: 124 Page(s): 2327 - 2336
    06/01/2018 Authors: Koff JL; Li J-X; Zhang X; Switchenko JM; Flowers CR; Waller EK
  • Targeting the B cell receptor pathway in non-Hodgkin lymphoma.
    Expert Opin Investig Drugs Volume: 27 Page(s): 513 - 522
    06/01/2018 Authors: Valla K; Flowers CR; Koff JL
  • Impact of individual comorbidities on post-transplant outcomes for elderly patients with non-Hodgkin lymphoma (NHL).
    Volume: 36
    05/20/2018 Authors: Ip A; Switchenko JM; Graiser M; Koff JL; Gupta VA; Lechowicz MJ; Nooka AK; Kaufman JL; Lonial S; Waller EK
  • Racial and socioeconomic disparities in mantle cell lymphoma.
    Volume: 36
    05/20/2018 Authors: Shah N; Liu Y; Xi Y; Flowers C; Koff JL; Behera M; Cohen JB
  • Outcomes in non-Hodgkin lymphoma by Latino country-of-origin (COO).
    Volume: 36
    05/20/2018 Authors: Calzada O; Xi Y; Behera M; Koff JL; Flowers C; Liu Y; Cohen JB
  • Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
    Biol Blood Marrow Transplant Volume: 24 Page(s): 973 - 982
    05/01/2018 Authors: Hosoba S; Waller EK; Shenvi N; Graiser M; Easley KA; Al-Kadhimi Z; Andoh A; Antun AG; Barclay S; Josephson CD
  • Effective management strategies for patients with marginal zone lymphoma.
    Future Oncol Volume: 14 Page(s): 1213 - 1222
    05/01/2018 Authors: Rosand CB; Valla K; Flowers CR; Koff JL
  • Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.
    Leuk Lymphoma Volume: 59 Page(s): 888 - 895
    04/01/2018 Authors: Guidot DM; Switchenko JM; Nastoupil LJ; Koff JL; Blum KA; Maly J; Flowers CR; Cohen JB
  • Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER-Medicare Cohort.
    Volume: 18 Page(s): e115 - e121
    02/01/2018 Authors: Koff JL; Rai A; Flowers CR
  • Genetic and Functional Drivers of Diffuse Large BCell Lymphoma.
    Cell Volume: 171 Page(s): 481 - 494.e15
    10/05/2017 Authors: Reddy A; Zhang J; Davis NS; Moffitt AB; Love CL; Waldrop A; Leppa S; Pasanen A; Meriranta L; Karjalainen-Lindsberg M-L
  • Prognostic modeling in diffuse large B-cell lymphoma in the era of immunochemotherapy: Where do we go from here?
    Cancer Volume: 123 Page(s): 3222 - 3225
    09/01/2017 Authors: Koff JL; Flowers CR
  • Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.
    Oncogene Volume: 36 Page(s): 4224 - 4232
    07/20/2017 Authors: Guo X; Koff JL; Moffitt AB; Cinar M; Ramachandiran S; Chen Z; Switchenko JM; Mosunjac M; Neill SG; Mann KP
  • Dose dependent association of early red blood cell transfusion with increased risk of graft versus host disease and worse survival after allogeneic hematopoietic stem cell transplantation
    Volume: 52 Page(s): S207 - S208
    07/01/2017 Authors: Waller EK; Hosoba S; Al-Kadhimi Z; Andoh A; Antun AG; Barclay S; Easley KA; Josephson CD; Khoury HJ; Koff JL
  • THE COST-EFFECTIVENESS OF PRECISION MEDICINE TREATMENT STRATEGIES FOR DIFFUSE LARGE B-CELL LYMPHOMA
    Volume: 20 Page(s): A107 - A107
    05/01/2017 Authors: Chen Q; Staton AD; Ayer T; Goldstein DA; Koff JL; Flowers CR
  • CD30 Expression Is Not Acquired at Time of Relapse in Diffuse Large B-Cell Lymphoma
    Volume: 128
    12/02/2016 Authors: Calzada O; Bradley KT; Switchenko J; Staton AD; Koff JL; Flowers CR; Cohen JB
  • An Evaluation of the Role of Surveillance Imaging in Mantle Cell Lymphoma in First Remission
    Volume: 128
    12/02/2016 Authors: Guidot DM; Switchenko J; Nastoupil LJ; Koff JL; Flowers C; Cohen JB
  • Assessing the Feasibility of Pathology Informatics Approaches for Subtyping Diffuse Large B-Cell Lymphoma (DLBCL)
    Volume: 128
    12/02/2016 Authors: Lewis SJ; Goldstein J; Farone M; Anh TP; Koff JL; Staton AD; Mobadersany P; Cooper L; Flowers C
  • Assessing the Feasibility of Pathology Informatics Approaches for Subtyping Diffuse Large B-Cell Lymphoma (DLBCL)
    Volume: 128
    12/02/2016 Authors: Lewis SJ; Goldstein J; Farone M; Anh TP; Koff JL; Staton AD; Mobadersany P; Cooper L; Flowers C
  • Relations Between Residential Proximity to EPA-Designated Toxic Release Sites and Diffuse Large B-Cell Lymphoma Incidence.
    South Med J Volume: 109 Page(s): 606 - 614
    10/01/2016 Authors: Bulka C; Nastoupil LJ; Koff JL; Bernal-Mizrachi L; Ward KC; Williams JN; Bayakly AR; Switchenko JM; Waller LA; Flowers CR
  • B cells gone rogue: the intersection of diffuse large B cell lymphoma and autoimmune disease.
    Expert Rev Hematol Volume: 9 Page(s): 553 - 561
    06/01/2016 Authors: Koff JL; Flowers CR
  • Resolving uncertainty in the spatial relationships between passive benzene exposure and risk of non-Hodgkin lymphoma.
    Cancer Epidemiol Volume: 41 Page(s): 139 - 151
    04/01/2016 Authors: Switchenko JM; Bulka C; Ward K; Koff JL; Bayakly AR; Ryan PB; Waller LA; Flowers CR
  • Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.
    Discov Med Volume: 21 Page(s): 181 - 188
    03/01/2016 Authors: Glass S; Phan A; Williams JN; Flowers CR; Koff JL
  • Emerging treatments in Castleman disease - a critical appraisal of siltuximab.
    Biologics Volume: 10 Page(s): 9 - 15
    01/01/2016 Authors: Koff JL; Lonial S
  • Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma.
    Leuk Lymphoma Volume: 57 Page(s): 842 - 851
    01/01/2016 Authors: Chen Q; Ayer T; Nastoupil LJ; Koff JL; Staton AD; Chhatwal J; Flowers CR
  • Complex Karyotype in Mantle Cell Lymphoma (MCL) Is Associated with Inferior Progression-Free Survival in Patients (pts) Receiving R-Hypercvad Followed By Autologous Stem Cell Transplant
    Volume: 126
    12/03/2015 Authors: Lee MJ; Switchenko J; Thomas JS; Koff JL; Nastoupil L; Lechowicz MJ; Langston AA; Flowers C; Cohen JB
  • A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma.
    Volume: 171 Page(s): 539 - 546
    11/01/2015 Authors: Cohen JB; Switchenko JM; Koff JL; Sinha R; Kaufman JL; Khoury HJ; Bumpers N; Colbert A; Hutchison-Rzepka A; Nastoupil LJ
  • Reply to Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphoma.
    Cancer Volume: 121 Page(s): 3748
    10/15/2015 Authors: Williams JN; Koff JL; Flowers CR
  • To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes.
    Curr Hematol Malig Rep Volume: 10 Page(s): 244 - 255
    09/01/2015 Authors: Koff JL; Chihara D; Phan A; Nastoupil LJ; Williams JN; Flowers CR
  • Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma.
    Cancer Volume: 121 Page(s): 1800 - 1808
    06/01/2015 Authors: Williams JN; Rai A; Lipscomb J; Koff JL; Nastoupil LJ; Flowers CR
  • New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy.
    Expert Rev Anticancer Ther Volume: 15 Page(s): 531 - 544
    05/01/2015 Authors: Chihara D; Nastoupil LJ; Williams JN; Lee P; Koff JL; Flowers CR
  • Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States.
    Leuk Lymphoma Volume: 56 Page(s): 1295 - 1302
    05/01/2015 Authors: Nastoupil LJ; Sinha R; Byrtek M; Ziemiecki R; Taylor M; Friedberg JW; Koff JL; Link BK; Cerhan JR; Dawson KL
  • Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.
    Leuk Lymphoma Volume: 56 Page(s): 383 - 389
    02/01/2015 Authors: Nastoupil LJ; Shenoy PJ; Ambinder A; Koff JL; Nooka AK; Waller EK; Langston A; Seward M; Kaufman JL; Bernal-Mizrachi L
  • A time to kill: targeting apoptosis in cancer.
    Int J Mol Sci Volume: 16 Page(s): 2942 - 2955
    01/28/2015 Authors: Koff JL; Ramachandiran S; Bernal-Mizrachi L
  • Next-generation prognostic assessment for diffuse large B-cell lymphoma.
    Future Oncol Volume: 11 Page(s): 2443 - 2457
    01/01/2015 Authors: Staton AD; Koff JL; Chen Q; Ayer T; Flowers CR
  • Insurance Status Impacts Survival in Follicular Lymphoma
    BLOOD Volume: 124
    12/06/2014 Authors: Nastoupil LJ; Han X; Jemal A; Ward E; Flowers CR
  • Detection of NFKB2 3'end Loos By Quantitative PCR (QPCR) or Detection of NFKB2 Rearrangements Correlate with Bortezomib Response in Multiple Myeloma
    Volume: 124
    12/06/2014 Authors: Ramachandiran S; Koff JL; Garderet L; Saxe D; Ikhlef S; Kelkar N; Kaplan L; El-Cheikh J; Switchenko JM; Sunay S
  • Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms.
    Clin Lymphoma Myeloma Leuk Volume: 14 Page(s): 460 - 467.e2
    12/01/2014 Authors: Read JA; Koff JL; Nastoupil LJ; Williams JN; Cohen JB; Flowers CR
  • Puffing the 'Activate' in Activated B Cell-like Diffuse Large B Cell Lymphoma: A Role for the Noncanonical NF-kappa B Pathway
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Volume: 14 Page(s): S143 - S143
    09/01/2014 Authors: Koff JL; Guo X; Ramachandiran S; Switchenko JM; Mosunjac MB; Neill SG; Mann K; Bagirov M; Flowers CR; Lossos IS
  • Relationship Between Residential Proximity To Environmental Protection Agency (EPA) Designated Toxic Release Sites and The Risk Of Diffuse Large B-Cell Lymphoma (DLBCL)
    Volume: 122
    11/15/2013 Authors: Bulka C; Nastoupil LJ; Koff J; Bernal L; Ward K; Bayakly R; Switchenko J; Waller L; Flowers CR
  • Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies.
    Oncology (Williston Park) Volume: 27 Suppl 2 Page(s): 8 - 12
    10/01/2013 Authors: Nastoupil LJ; Koff JL; Flowers CR
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements